Acta pharmacologica Sinica · 2002
Metabolism of roxithromycin in phenobarbital-treated rat liver microsomes.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhong Da-Fang, Zhang Shu-Qiu, Sun Lu, Zhao Xiao-Yun
Аннотация
AIM: To investigate the metabolism of roxithromycin (RXM) in rat liver microsomes and the possible effects of RXM and its metabolites on cytochrome P-450 (CYP450).
METHODS: Liver microsomes of Wistar rats, induced by phenobarbital, were prepared using ultracentrifuge method. RXM in vitro metabolism was stu died with the microsome incubation. The metabolites were separated and assayed by li quid chromatography-tandem mass spectrometry (LC-MSn), and were further identified by comparison of their mass spectra and LC behavior to synthesized references.
RESULTS: N-Mono- and N-di-demethyl metabolites a s well as O-dealkylated metabolite (erythromycin oxime) were detected in microsomal incubates. RXM and its metabolites expressed weak potency to form inactive complexes with CYP450.
CONCLUSION: N-Demethylation and oxime ether side chain O- dealkylation are main biotransformation pathways of RXM in phenobarbital-treated rat liver microsomes. Both routes were found to be NADPH-dependent. RXM and its metabolites showed weak inhibitory effects on CYP450.
METHODS: Liver microsomes of Wistar rats, induced by phenobarbital, were prepared using ultracentrifuge method. RXM in vitro metabolism was stu died with the microsome incubation. The metabolites were separated and assayed by li quid chromatography-tandem mass spectrometry (LC-MSn), and were further identified by comparison of their mass spectra and LC behavior to synthesized references.
RESULTS: N-Mono- and N-di-demethyl metabolites a s well as O-dealkylated metabolite (erythromycin oxime) were detected in microsomal incubates. RXM and its metabolites expressed weak potency to form inactive complexes with CYP450.
CONCLUSION: N-Demethylation and oxime ether side chain O- dealkylation are main biotransformation pathways of RXM in phenobarbital-treated rat liver microsomes. Both routes were found to be NADPH-dependent. RXM and its metabolites showed weak inhibitory effects on CYP450.